ABVC BioPharma, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities
ABVC BioPharma, Inc. (ABVC) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of $577.67 thousand as of 2019-02-08, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Liability Assumed, Liability
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities · last filed 2022-11-14
- 2019-02-08: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $577.67K.
- 2018-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $85.91K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |
|---|---|
| 2019-02-08 | $577.67K 10-Q · filed 2022-11-14 |
| 2018-12-31 | $85.91K 10-K · filed 2019-04-15 |